Integrative Analysis of Androgen Receptor Interactors Aberrations and Associated Prognostic Significance in Prostate

Zhu Wang1, Ying Zhang2, Qiong Deng3

  • 1Urology Department, Affiliated Hospital of Longhua Shenzhen, Southern Medical University, Shenzhen, Guangdong 518109, China. wangzhu1223@hotmail.com.

Urology Journal
|September 5, 2023
PubMed
Abstract

Insights

Aberrations in androgen receptor (AR) interactors are linked to poor prognosis in advanced prostate cancer. These AR interactors may serve as biomarkers for diagnosing and understanding metastatic castration-resistant prostate cancer (CRPC).

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Significant advancements have been made in targeting the androgen receptor (AR) pathway for prostate cancer treatment.
  • However, the development of AR-interactor-related metastatic castration-resistant prostate cancer (CRPC) remains a clinical challenge.

Purpose of the Study:

  • To characterize AR-interactor aberrations in advanced prostate cancer.
  • To investigate the therapeutic implications of these aberrations.

Main Methods:

  • Utilized the STRING database, UALCAN web portal, and cBioPortal platform to analyze the AR interaction network, gene alterations, and prognostic significance.
  • Performed Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis for functional enrichment of AR-interactors.

Main Results:

  • Identified ten first-shell AR-interactors, with FOXA1 and PELP1 significantly upregulated, and CCND1, CTNNB1, NCOA4, and HSP90AA1 significantly downregulated.
  • The median survival for the altered group (n=227) was 70 months, compared to 141 months for the non-altered group (n=545) (P < 0.001).
  • Enrichment analysis revealed AR-interactors are notably enriched in prostate cancer, thyroid hormone signaling, and endocrine resistance pathways.

Conclusions:

  • AR-interactors show potential as diagnostic and prognostic markers for prostate cancer.
  • These findings offer new insights into the molecular mechanisms driving CRPC progression.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
5.3K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
Internal Receptors01:31

Internal Receptors

Many cellular signals are hydrophilic and therefore cannot pass through the plasma membrane. However, small or hydrophobic signaling molecules can cross the hydrophobic core of the plasma membrane and bind to internal, or intracellular, receptors that reside within the cell. Many mammalian steroid hormones use this mechanism of cell signaling, as does nitric oxide (NO) gas.
70.3K
Drug-Receptor Interaction: Agonist01:25

Drug-Receptor Interaction: Agonist

Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
2.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K